Jonathan Dixon
Algemeen Adviseur bij BIONANO GENOMICS, INC.
Vermogen: 2 675 $ op 30-04-2024
Profiel
Jonathan Dixon is currently the Global Head-Legal at Bionano Genomics, Inc. He previously worked as the Legal Director at GeneOhm Sciences, Inc., Associate General Counsel at Becton, Dickinson & Co., and Associate General Counsel at CareFusion Corp.
Dixon received his undergraduate degree from Brigham Young University and his graduate degree from Lewis & Clark Law School.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
BIONANO GENOMICS, INC.
0.01% | 15-02-2024 | 3 525 ( 0.01% ) | 2 675 $ | 30-04-2024 |
Actieve functies van Jonathan Dixon
Bedrijven | Functie | Begin |
---|---|---|
BIONANO GENOMICS, INC. | Algemeen Adviseur | 01-01-2023 |
Eerdere bekende functies van Jonathan Dixon
Bedrijven | Functie | Einde |
---|---|---|
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
CAREFUSION CORPORATION | Corporate Officer/Principal | - |
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Directeur/Bestuurslid | - |
Opleiding van Jonathan Dixon
Brigham Young University | Undergraduate Degree |
Lewis & Clark Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BIONANO GENOMICS, INC. | Health Technology |
BECTON, DICKINSON AND COMPANY | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
CareFusion Corp.
CareFusion Corp. Medical DistributorsDistribution Services CareFusion Corp. engages in the manufactures of medical equipment and device. The company was founded on February 4, 2009 and is headquartered in San Diego, CA. | Distribution Services |